Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
inhaled corticosteroids + salbutamol
- Development stage
- Unknown
- Lead developer
- AstraZeneca
- Modality
- Small Molecules
- Administration
- Inhalation
01
Overview
The combination of inhaled corticosteroids and salbutamol (albuterol) brings together two distinct mechanisms for treating respiratory conditions like asthma. This combination provides both immediate symptom relief and long-term inflammation control. Salbutamol is a short-acting beta-agonist (SABA) that provides quick relief by relaxing airway muscles during symptom flare-ups. Inhaled corticosteroids work to control symptoms by reducing and preventing swelling and inflammation in airway tissue. When combined, these medications can effectively reduce asthma symptoms and prevent asthma attacks. The combination may be delivered through a single inhaler device (as with AIRSUPRA) or through separate inhalers.
- Brand names
- AIRSUPRA
- Other names
- inhaled corticosteroids + albuterol
02
Targets
GR (Glucocorticoid receptor)ADRB2 (β2)
Beyond the preview
Go deeper on inhaled corticosteroids + salbutamol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on inhaled corticosteroids + salbutamol.